Ribosomal protein S29 pseudogene 23 (RPS29P23)

RPS29P23 is a processed pseudogene that originated from the ribosomal protein S29 (RPS29) gene. Pseudogenes are generally non-functional, arising by duplication or retrotransposition events and lacking coding potential. RPS29P23 does not encode a protein and has no reported biological function, clinical relevance, or drug interactions. In contrast, the parent RPS29 gene encodes a component of the 40S ribosomal subunit involved in protein synthesis and is implicated in Diamond–Blackfan anemia when mutated[1][3][4][6][7][8]. The designation "ribosomal protein S29 pseudogene 23" is not a known receptor, enzyme, drug target, or biomarker. It is a non-functional RNA fragment annotated in the human genome as a pseudogene, with no evidence for a biological or therapeutic role. This entry is commonly mistaken as a valid target due to its similarity in naming to the functional ribosomal protein S29 gene, but only the parent gene has established biology and disease associations[7][8].

Other names

RPS29_17_1627RPS29P23Ribosomal Protein S29 Pseudogene 23GC19U901046GC19P012485